PhytoHealth Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	134.58	153.56	162.49	135.47	168.94
Revenue Growth (YoY)	-12.36%	-5.49%	19.95%	-19.81%	84.01%
Cost of Revenue	93.28	89.56	94.85	78.43	90.62
Gross Profit	41.29	64.01	67.64	57.03	78.31
Selling, General & Admin	89.72	95.68	96.73	94.23	90.06
Research & Development	126.15	128.51	92.59	119.52	120.47
Operating Expenses	215.87	224.19	189.32	213.7	210.42
Operating Income	-174.58	-160.18	-121.68	-156.66	-132.11
Interest Expense	-0.38	-0.34	-0.34	-0.31	-0.41
Interest & Investment Income	18.04	45.87	41.19	36.31	29.66
Currency Exchange Gain (Loss)	-	0.11	0.2	1.61	2.09
Other Non Operating Income (Expenses)	46.8	6.09	6.58	4.27	5.29
EBT Excluding Unusual Items	-110.11	-108.45	-74.05	-114.78	-95.48
Gain (Loss) on Sale of Investments	-	0.1	0.07	0.07	0.04
Gain (Loss) on Sale of Assets	-	-0.19	-0.17	-0.01	-0.08
Other Unusual Items	-	-	0	-	-
Pretax Income	-110.11	-108.53	-74.15	-114.72	-95.52
Income Tax Expense	-0.02	-	-	-	-
Earnings From Continuing Operations	-110.1	-108.53	-74.15	-114.72	-95.52
Minority Interest in Earnings	51.9	35.03	27.03	35.31	17.8
Net Income	-58.2	-73.5	-47.12	-79.41	-77.72
Net Income to Common	-58.2	-73.5	-47.12	-79.41	-77.72
Shares Outstanding (Basic)	201	199	199	199	196
Shares Outstanding (Diluted)	201	199	199	199	196
Shares Change (YoY)	1.04%	-	-	1.49%	19.61%
EPS (Basic)	-0.29	-0.37	-0.24	-0.40	-0.40
EPS (Diluted)	-0.29	-0.37	-0.24	-0.40	-0.40
Free Cash Flow	-45.26	-54.85	-59.68	-61.55	-81.46
Free Cash Flow Per Share	-0.23	-0.28	-0.30	-0.31	-0.42
Gross Margin	30.68%	41.68%	41.63%	42.10%	46.36%
Operating Margin	-129.73%	-104.31%	-74.88%	-115.65%	-78.20%
Profit Margin	-43.25%	-47.86%	-29.00%	-58.62%	-46.00%
Free Cash Flow Margin	-33.63%	-35.72%	-36.73%	-45.44%	-48.22%
EBITDA	-125.51	-118.32	-79.16	-114.85	-90.16
EBITDA Margin	-93.26%	-77.05%	-48.72%	-84.78%	-53.37%
D&A For EBITDA	49.07	41.87	42.52	41.82	41.95
EBIT	-174.58	-160.18	-121.68	-156.66	-132.11
EBIT Margin	-129.73%	-104.31%	-74.88%	-115.65%	-78.20%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.